Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation

The initial experience in Taiwan

Yi Hsiang Lin, Ting Kai Leung, Hung Jung Wang, Ching Huei Kung, Han Yun Hsiao, Yu Ching Ting, Ya Yen Chen, Chi Ming Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Uterine leiomyomas (fibroids) are the most common benign neoplasm in women of child-bearing age. Magnetic resonance-guided focused ultrasound ablation (MRgFUS) has been used worldwide to treat symptomatic uterine fibroids over the past few years. This paper describes our experiences with three patients that were treated with MRgFUS for uterine fibroids and their follow-up status after 3 months. Three patients with uterine fibroids underwent MRgFUS on February, 2009. Before the treatment and at 3 months post-treatment, we used the Uterine Fibroid Symptoms and Quality of Life Questionnaire (UFS-QOL) to determine symptom severity scores (SSS). We also evaluate the change in fibroid volume after 3 months using T1-weighted contrast enhanced MRI images. No serious or unexpected adverse events arose during the study. All patients were followed up for 3 months. The fibroid volume reduction after 3 months was 30.8% in average, and SSS reduction after 3 months was 30.6%. Our results demonstrate that MRgFUS can safely and effectively ablate uterine fibroids to produce a significant decrease in mean fibroid volume and improvement in SSS for up to 3 months post-treatment. 271.

Original languageEnglish
Pages (from-to)263-271
Number of pages9
JournalChinese Journal of Radiology
Volume34
Issue number4
Publication statusPublished - Dec 2009

Fingerprint

Leiomyoma
Taiwan
Magnetic Resonance Spectroscopy
Therapeutics
Quality of Life

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Lin, Y. H., Leung, T. K., Wang, H. J., Kung, C. H., Hsiao, H. Y., Ting, Y. C., ... Lee, C. M. (2009). Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation: The initial experience in Taiwan. Chinese Journal of Radiology, 34(4), 263-271.

Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation : The initial experience in Taiwan. / Lin, Yi Hsiang; Leung, Ting Kai; Wang, Hung Jung; Kung, Ching Huei; Hsiao, Han Yun; Ting, Yu Ching; Chen, Ya Yen; Lee, Chi Ming.

In: Chinese Journal of Radiology, Vol. 34, No. 4, 12.2009, p. 263-271.

Research output: Contribution to journalArticle

Lin, YH, Leung, TK, Wang, HJ, Kung, CH, Hsiao, HY, Ting, YC, Chen, YY & Lee, CM 2009, 'Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation: The initial experience in Taiwan', Chinese Journal of Radiology, vol. 34, no. 4, pp. 263-271.
Lin, Yi Hsiang ; Leung, Ting Kai ; Wang, Hung Jung ; Kung, Ching Huei ; Hsiao, Han Yun ; Ting, Yu Ching ; Chen, Ya Yen ; Lee, Chi Ming. / Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation : The initial experience in Taiwan. In: Chinese Journal of Radiology. 2009 ; Vol. 34, No. 4. pp. 263-271.
@article{bc8b7bfb7d534732995b7b6dbe4bb86d,
title = "Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation: The initial experience in Taiwan",
abstract = "Uterine leiomyomas (fibroids) are the most common benign neoplasm in women of child-bearing age. Magnetic resonance-guided focused ultrasound ablation (MRgFUS) has been used worldwide to treat symptomatic uterine fibroids over the past few years. This paper describes our experiences with three patients that were treated with MRgFUS for uterine fibroids and their follow-up status after 3 months. Three patients with uterine fibroids underwent MRgFUS on February, 2009. Before the treatment and at 3 months post-treatment, we used the Uterine Fibroid Symptoms and Quality of Life Questionnaire (UFS-QOL) to determine symptom severity scores (SSS). We also evaluate the change in fibroid volume after 3 months using T1-weighted contrast enhanced MRI images. No serious or unexpected adverse events arose during the study. All patients were followed up for 3 months. The fibroid volume reduction after 3 months was 30.8{\%} in average, and SSS reduction after 3 months was 30.6{\%}. Our results demonstrate that MRgFUS can safely and effectively ablate uterine fibroids to produce a significant decrease in mean fibroid volume and improvement in SSS for up to 3 months post-treatment. 271.",
author = "Lin, {Yi Hsiang} and Leung, {Ting Kai} and Wang, {Hung Jung} and Kung, {Ching Huei} and Hsiao, {Han Yun} and Ting, {Yu Ching} and Chen, {Ya Yen} and Lee, {Chi Ming}",
year = "2009",
month = "12",
language = "English",
volume = "34",
pages = "263--271",
journal = "Chinese Journal of Radiology",
issn = "1018-8940",
publisher = "中華民國放射線醫學會",
number = "4",

}

TY - JOUR

T1 - Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation

T2 - The initial experience in Taiwan

AU - Lin, Yi Hsiang

AU - Leung, Ting Kai

AU - Wang, Hung Jung

AU - Kung, Ching Huei

AU - Hsiao, Han Yun

AU - Ting, Yu Ching

AU - Chen, Ya Yen

AU - Lee, Chi Ming

PY - 2009/12

Y1 - 2009/12

N2 - Uterine leiomyomas (fibroids) are the most common benign neoplasm in women of child-bearing age. Magnetic resonance-guided focused ultrasound ablation (MRgFUS) has been used worldwide to treat symptomatic uterine fibroids over the past few years. This paper describes our experiences with three patients that were treated with MRgFUS for uterine fibroids and their follow-up status after 3 months. Three patients with uterine fibroids underwent MRgFUS on February, 2009. Before the treatment and at 3 months post-treatment, we used the Uterine Fibroid Symptoms and Quality of Life Questionnaire (UFS-QOL) to determine symptom severity scores (SSS). We also evaluate the change in fibroid volume after 3 months using T1-weighted contrast enhanced MRI images. No serious or unexpected adverse events arose during the study. All patients were followed up for 3 months. The fibroid volume reduction after 3 months was 30.8% in average, and SSS reduction after 3 months was 30.6%. Our results demonstrate that MRgFUS can safely and effectively ablate uterine fibroids to produce a significant decrease in mean fibroid volume and improvement in SSS for up to 3 months post-treatment. 271.

AB - Uterine leiomyomas (fibroids) are the most common benign neoplasm in women of child-bearing age. Magnetic resonance-guided focused ultrasound ablation (MRgFUS) has been used worldwide to treat symptomatic uterine fibroids over the past few years. This paper describes our experiences with three patients that were treated with MRgFUS for uterine fibroids and their follow-up status after 3 months. Three patients with uterine fibroids underwent MRgFUS on February, 2009. Before the treatment and at 3 months post-treatment, we used the Uterine Fibroid Symptoms and Quality of Life Questionnaire (UFS-QOL) to determine symptom severity scores (SSS). We also evaluate the change in fibroid volume after 3 months using T1-weighted contrast enhanced MRI images. No serious or unexpected adverse events arose during the study. All patients were followed up for 3 months. The fibroid volume reduction after 3 months was 30.8% in average, and SSS reduction after 3 months was 30.6%. Our results demonstrate that MRgFUS can safely and effectively ablate uterine fibroids to produce a significant decrease in mean fibroid volume and improvement in SSS for up to 3 months post-treatment. 271.

UR - http://www.scopus.com/inward/record.url?scp=77952806176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952806176&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 263

EP - 271

JO - Chinese Journal of Radiology

JF - Chinese Journal of Radiology

SN - 1018-8940

IS - 4

ER -